Experimental evidence based on studies involving human APP transgenic mice suggests that memory deficits can be prevented via BACE-1 gene deletion [7], and reportedly Aβ aggregates can act as pathogenic mediators, inducing oxidative stress, neuroinflammation, and BACE-1 expression, which further exacerbate AD [8]. Here, BACE1 is linked to Alzheimer disease.